Martin Pesl

Dr. Martin Pesl

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
GNGiorgia Nardone
Giorgia Nardone
JCJorge Oliver-De La Cruz
Jorge Oliver-De La Cruz
JVJan Vrbsky
Jan Vrbsky
CMCecilia Martini
Cecilia Martini
JPJan Pribyl
Jan Pribyl
GFGiancarlo Forte
Giancarlo Forte
Hippo effectors YAP/TAZ act as on–off mechanosensing switches by sensing modifications in extracellular matrix (ECM) composition and mechanics. The regulation of their activity has been described by a hierarchical model in which elements of Hippo pathway are under the control of focal adhesions (FAs). Here we unveil the molecular mechanism by which cell spreading and RhoA GTPase activity control FA formation through YAP to stabilize the anchorage of the actin cytoskeleton to the cell membrane. This mechanism requires YAP co-transcriptional function and involves the activation of genes encoding for integrins and FA docking proteins. Tuning YAP transcriptional activity leads to the modification of cell mechanics, force development and adhesion strength, and determines cell shape, migration and differentiation. These results provide new insights into the mechanism of YAP mechanosensing activity and qualify this Hippo effector as the key determinant of cell mechanics in response to ECM cues.

1 January 2019 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
GCGuido Caluori
Guido Caluori
JPJan Pribyl
Jan Pribyl
MPMartin Pesl
Martin Pesl
SJSarka Jelinkova
Sarka Jelinkova
VRVladimir Rotrekl
Vladimir Rotrekl
Roberto RaiteriRoberto Raiteri
Roberto Raiteri

1 November 2016 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
MPMartin Pesl
Martin Pesl
JPJan Pribyl
Jan Pribyl
IAIvana Acimovic
Ivana Acimovic
AVAleksandra Vilotic
Aleksandra Vilotic
SJSarka Jelinkova
Sarka Jelinkova
VRVladimir Rotrekl
Vladimir Rotrekl

21 November 2013 in Heart and Vessels
Verified
Journal Article
Closed access
PDF file
MPMartin Pesl
Martin Pesl
IAIvana Acimovic
Ivana Acimovic
JPJan Pribyl
Jan Pribyl
RHRenata Hezova
Renata Hezova
AVAleksandra Vilotic
Aleksandra Vilotic
AMAlbano Meli
Albano Meli

1 January 2014 in BioMed Research International
Verified
Journal Article
Open access
PDF file
IAIvana Acimovic
Ivana Acimovic
AVAleksandra Vilotic
Aleksandra Vilotic
MPMartin Pesl
Martin Pesl
ALAlain Lacampagne
Alain Lacampagne
PDPetr Dvorak
Petr Dvorak
AMAlbano Meli
Albano Meli
Human pluripotent stem cells (hPSCs), namely, embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs), with their ability of indefinite self-renewal and capability to differentiate into cell types derivatives of all three germ layers, represent a powerful research tool in developmental biology, for drug screening, disease modelling, and potentially cell replacement therapy. Efficient differentiation protocols that would result in the cell type of our interest are needed for maximal exploitation of these cells. In the present work, we aim at focusing on the protocols for differentiation of hPSCs into functional cardiomyocytesin vitroas well as achievements in the heart disease modelling and drug testing on the patient-specific iPSC-derived cardiomyocytes (iPSC-CMs).

1 May 2009 in Journal of the American Society of Echocardiography
Verified
Journal Article
Closed access
JMJaroslav Meluzin
Jaroslav Meluzin
LSLenka Spinarova
Lenka Spinarova
PHPetr Hude
Petr Hude
JKJan Krejci
Jan Krejci
HPHana Poloczkova
Hana Poloczkova
JKJosef Korinek
Josef Korinek